Matches in Nanopublications for { ?s ?p "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.
- SENTENCE label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." provenance.